• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: -

Seligson & Co Global Top 25 Pharmac.

+ Add to Watchlist

SEL25PB:FH

11.77 EUR 0.000.00%

As of 01:59:30 ET on 10/20/2014.

Snapshot for Seligson & Co Global Top 25 Pharmac. (SEL25PB)

Year To Date: +14.32% 3-Month: +5.07% 3-Year: +21.18% 52-Week Range: 9.74 - 12.61
1-Month: -4.98% 1-Year: +20.56% 5-Year: +17.07% Beta vs HEXP: 0.58

Mutual Fund Chart for SEL25PB

No chart data available.
  • SEL25PB:FH 11.77
  • 1M
  • 1Y
Interactive SEL25PB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SEL25PB

Seligson & Co Global Top 25 Pharmaceuticals is an open-end fund incorporated in Finland. The Fund's objective is a return that follows the return of the world's top 25 pharmaceutical companies. The Fund invests in a basket of equities of the world's top 25 pharmaceutical companies.

Inception Date: 01-15-2000 Telephone: 358-9-6817-8200
Managers: JANI HOLMBERG / JAANA TIMONEN
Web Site: www.seligson.fi/

Fundamentals for SEL25PB

NAV (on 2014-10-20) 11.77
Assets (M) (on 2014-09-30) 165.11
Fund Leveraged N
Minimum Investment 1.00
Minimum Subsequent Investment 1.00

Dividends for SEL25PB

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for SEL25PB

Front Load 0.00
Back Load 0.50
Current Mgmt Fee 0.50
Redemption Fee 0.50
12b1 Fee -
Expense Ratio 0.61

Top Fund Holdings for SEL25PB

Filing Date: 08/29/2014
Name Position Value % of Total
Merck & Co Inc 235,654 10,739,524 7.000%
Novartis AG 147,117 10,039,160 6.544%
Johnson & Johnson 122,355 9,567,288 6.236%
Roche Holding AG 42,101 9,348,408 6.093%
Pfizer Inc 364,149 8,123,536 5.295%
Allergan Inc/United States 59,770 7,362,557 4.799%
Gilead Sciences Inc 78,433 6,402,682 4.173%
AstraZeneca PLC 105,445 6,081,245 3.964%
Novo Nordisk A/S 169,831 5,916,202 3.856%
Teva Pharmaceutical Industries 144,762 5,727,827 3.733%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil